Finance

Lists
LUNG:NASDAQ
Pulmonx Corp
$2.07
+4.55%
(+0.090) 1D
$2.10
+1.45% (+0.030)
After hours
Closed: Sep 18, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for LUNG...
Open
$1.99
High
$2.08
Low
$1.99
Mkt. cap
88.90M
Avg. vol.
444.99K
Volume
430.08K
52-wk high
$2.89
52-wk low
$1.13
EPS
-$1.16
Beta
0.34
Shares outstanding
42.95M
No. of employees
296
Open
$1.99
High
$2.08
Low
$1.99
Mkt. cap
88.90M
Avg. vol.
444.99K
Volume
430.08K
52-wk high
$2.89
52-wk low
$1.13
EPS
-$1.16
Beta
0.34
Shares outstanding
42.95M
No. of employees
296
News stories
From web sources and news partners
About Pulmonx Corp
CEO-
Employees296
Founded1995
HeadquartersRedwood City, California, United States
SectorMedical device
Websitepulmonx.com
Analyst ratings
Based on 4 analysts giving stock ratings to LUNG in the past 3 months
Strong buy
Buy
3
Hold
1
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for LUNG in the last 3 months.
Highest
Current $2.07
$5.00 (+141.55%)
Average
$3.50 (+69.08%)
Lowest
$2.50 (+20.77%)
Analyst
Recommendation
Action
Price target
Projected
Date
John Young CFA
Canaccord Genuity
Buy
Maintained
$5.00
+141.5%
08/11/2026
Rick Wise
Stifel Nicolaus
Buy
Maintained
$2.50
+20.8%
07/30/2026
Frank Takkinen
Lake Street
Buy
Reiterated
$4.00
+93.2%
07/30/2026
Jason Bednar
Piper Sandler
Hold
Maintained
$2.50
+20.8%
07/30/2026
William Plovanic
Canaccord Genuity
Buy
Reiterated
$5.00
+141.5%
04/30/2026
Last report
Jul 29, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
-$0.24 / -$0.28
+14.29%beat
Revenue / Est. (USD)
22.76M / 22.50M
+1.14%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
21.50M
22.60M
20.59M
22.76M
Cost of goods sold
5.45M
5.06M
4.54M
5.01M
Cost of revenue
5.45M
5.06M
4.54M
5.01M
Research and development expenses
4.85M
4.58M
4.90M
5.03M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
25.60M
22.86M
24.10M
21.76M
Operating expense
30.44M
27.44M
29.00M
26.80M
Total operating expenses
35.90M
32.50M
33.54M
31.81M
Operating income
-14.39M
-9.90M
-12.96M
-9.06M
Other non operating income
-42.00K
81.00K
277.00K
99.00K
EBT including unusual items
-13.83M
-10.24M
-13.50M
-9.95M
EBT excluding unusual items
-13.83M
-10.24M
-13.50M
-9.95M
Income tax expense
128.00K
186.00K
149.00K
133.00K
Effective tax rate
-0.93%
-1.82%
-1.10%
-1.34%
Other operating expenses
-
-
-
-
Net income
-13.96M
-10.42M
-13.65M
-10.08M
Net profit margin
-64.91%
-46.13%
-66.33%
-44.30%
Earnings per share
-0.34
-0.25
-0.33
-0.24
Interest and investment income
611.00K
453.00K
350.00K
329.00K
Interest expense
-805.00K
-770.00K
-976.00K
-1.22M
Net interest expenses
-194.00K
-317.00K
-626.00K
-889.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-14.25M
-9.57M
-12.84M
-8.84M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps